![]() The Inflation Reduction Act already caps Medicare patient out-of-pocket costs for insulin at $35 a month. The list also includes several versions of Novo Nordisk’s Fiasp, a fast-acting insulin taken around meals. Other drugs on the list include AstraZeneca’s diabetes and heart failure treatment Farxiga and three drugs from Johnson & Johnson: the blood thinner Xarelto, the blood cancer treatment Imbruvica and it’s biggest seller, Stelara, an IV treatment for psoriasis and other inflammatory disorders. READ MORE: Biden says he will request more funding for a new COVID-19 vaccine It also included Amgen’s autoimmune disease treatment Enbrel and Entresto from Novartis, which is used to treat heart failure. ![]() and Boehringer Ingelheim and Januvia from Merck made the list. ![]() The diabetes treatments Jardiance from Eli Lilly and Co. They said 8.2 million people with Medicare Part D prescription drug coverage take them. Senior administration officials said Tuesday that the 10 drugs selected for negotiation are among the most costly to the Medicare program. The drug from Pfizer and Bristol-Myers Squibb treats blood clots in the legs and lungs and reduces the risk of stroke in people with an irregular heartbeat called atrial fibrillation. That includes more than $16 billion on Eliquis. The drugs on the list announced Tuesday accounted for more than $50 billion in Medicare prescription drug costs between June 1, 2022, and May 31, according to the Centers for Medicare and Medicaid Services, or CMS. He’ll be joined by Vice President Kamala Harris. READ MORE: What are the 10 drugs to be negotiated by Medicare?īiden plans to deliver a speech on health care costs from the White House later Tuesday. “That is why we will continue the fight to lower healthcare costs - and we will not stop until we finish the job.” ![]() “For many Americans, the cost of one drug is the difference between life and death, dignity and dependence, hope and fear,” Biden said in a statement. But like the drug negotiations, many of Biden’s biggest policy moves take time to roll out, and his challenge is to persuade the public to be patient. The effort is a centerpiece of President Joe Biden’s reelection pitch as the Democrat seeks to show Americans he’s deserving of a second term because of the work he’s doing to lower costs for them while the country is struggling with inflation. The move is expected to cut costs for many patients, but it faces litigation from drugmakers and heavy criticism from Republican lawmakers, and it will be years before consumers notice any savings. The administration on Tuesday released a list of the 10 drugs for which prices will be negotiated directly with the manufacturer. Watch Biden’s remarks in the player above. WASHINGTON (AP) - The Biden administration is targeting the blood thinner Eliquis, diabetes treatment Jardiance and eight other medications for Medicare’s first-ever drug price negotiations as it seeks to lower medical costs for Americans. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |